$2.12 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 114 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | DENDREON CORPnote 2.875% 1/1 | $84,440,000 | – | 114,140,000 | +100.0% | 3.98% | – | |
AUXL | New | AUXILIUM PHARMACEUTICALS INC | $80,671,000 | – | 4,850,644 | +100.0% | 3.80% | – |
CBST | New | CUBIST PHARMACEUTICALS INCcall | $72,435,000 | – | 1,500,000 | +100.0% | 3.41% | – |
New | EXELIXIS INCnote 4.250% 8/1 | $65,448,000 | – | 67,000,000 | +100.0% | 3.08% | – | |
New | NUVASIVE INCnote 2.750% 7/0 | $61,050,000 | – | 61,136,000 | +100.0% | 2.88% | – | |
NXTM | New | NXSTAGE MEDICAL INC | $55,834,000 | – | 3,909,914 | +100.0% | 2.63% | – |
PFE | New | PFIZER INC | $51,959,000 | – | 1,855,000 | +100.0% | 2.45% | – |
ARRY | New | ARRAY BIOPHARMA INC | $49,420,000 | – | 10,885,406 | +100.0% | 2.33% | – |
TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $48,716,000 | – | 1,242,759 | +100.0% | 2.30% | – |
New | HOLOGIC INCdebt 2.000% 3/0 | $47,567,000 | – | 47,516,000 | +100.0% | 2.24% | – | |
New | VOLCANO CORPORATIONnote 1.750%12/0 | $46,129,000 | – | 50,000,000 | +100.0% | 2.17% | – | |
AZN | New | ASTRAZENECA PLCsponsored adr | $43,894,000 | – | 928,000 | +100.0% | 2.07% | – |
KERX | New | KERYX BIOPHARMACEUTICALS INC | $43,809,000 | – | 5,864,612 | +100.0% | 2.06% | – |
OPTR | New | OPTIMER PHARMACEUTICALS INC | $43,784,000 | – | 3,025,829 | +100.0% | 2.06% | – |
SGNT | New | SAGENT PHARMACEUTICALS INC | $43,684,000 | – | 2,082,167 | +100.0% | 2.06% | – |
New | INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1 | $40,589,000 | – | 41,523,000 | +100.0% | 1.91% | – | |
ATRS | New | ANTARES PHARMA INC | $39,104,000 | – | 9,400,000 | +100.0% | 1.84% | – |
FRX | New | FOREST LABS INC | $38,745,000 | – | 945,000 | +100.0% | 1.83% | – |
INFI | New | INFINITY PHARMACEUTICALS INC | $38,132,000 | – | 2,354,963 | +100.0% | 1.80% | – |
New | INTERMUNE INCnote 2.500% 9/1 | $34,061,000 | – | 41,570,000 | +100.0% | 1.60% | – | |
NKTR | New | NEKTAR THERAPEUTICS | $33,954,000 | – | 2,939,741 | +100.0% | 1.60% | – |
CBST | New | CUBIST PHARMACEUTICALS INC | $33,562,000 | – | 695,000 | +100.0% | 1.58% | – |
CAH | New | CARDINAL HEALTH INC | $33,040,000 | – | 700,000 | +100.0% | 1.56% | – |
AGN | New | ALLERGAN INC | $31,615,000 | – | 375,300 | +100.0% | 1.49% | – |
ANGO | New | ANGIODYNAMICS INC | $29,909,000 | – | 2,651,466 | +100.0% | 1.41% | – |
CYH | New | COMMUNITY HEALTH SYS INC NEW | $29,821,000 | – | 636,124 | +100.0% | 1.41% | – |
New | BROOKDALE SR LIVING INCnote 2.750% 6/1 | $29,466,000 | – | 25,000,000 | +100.0% | 1.39% | – | |
AIRM | New | AIR METHODS CORP | $29,425,000 | – | 869,025 | +100.0% | 1.39% | – |
TRNX | New | TORNIER N V | $28,811,000 | – | 1,646,318 | +100.0% | 1.36% | – |
UAM | New | UNIVERSAL AMERN CORP NEW | $27,248,000 | – | 3,065,003 | +100.0% | 1.28% | – |
CTRX | New | CATAMARAN CORPcall | $26,818,000 | – | 550,000 | +100.0% | 1.26% | – |
MRK | New | MERCK & CO INC NEW | $26,709,000 | – | 575,000 | +100.0% | 1.26% | – |
FLML | New | FLAMEL TECHNOLOGIES SAsponsored adr | $26,599,000 | – | 4,333,475 | +100.0% | 1.25% | – |
ABBV | New | ABBVIE INC | $25,507,000 | – | 617,000 | +100.0% | 1.20% | – |
AGN | New | ALLERGAN INCcall | $25,272,000 | – | 300,000 | +100.0% | 1.19% | – |
STJ | New | ST JUDE MED INC | $23,956,000 | – | 525,000 | +100.0% | 1.13% | – |
AET | New | AETNA INC NEW | $22,239,000 | – | 350,000 | +100.0% | 1.05% | – |
ARIA | New | ARIAD PHARMACEUTICALS INC | $22,127,000 | – | 1,265,104 | +100.0% | 1.04% | – |
New | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $21,778,000 | – | 23,000,000 | +100.0% | 1.03% | – | |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $21,514,000 | – | 694,000 | +100.0% | 1.01% | – |
HTWR | New | HEARTWARE INTL INC | $21,416,000 | – | 225,167 | +100.0% | 1.01% | – |
MOH | New | MOLINA HEALTHCARE INC | $21,193,000 | – | 570,000 | +100.0% | 1.00% | – |
CYTK | New | CYTOKINETICS INC | $20,590,000 | – | 1,779,622 | +100.0% | 0.97% | – |
CLVS | New | CLOVIS ONCOLOGY INC | $20,497,000 | – | 306,018 | +100.0% | 0.97% | – |
New | ACCURAY INCnote 3.750% 8/0 | $20,326,000 | – | 21,200,000 | +100.0% | 0.96% | – | |
XNPT | New | XENOPORT INC | $20,147,000 | – | 4,070,090 | +100.0% | 0.95% | – |
HCA | New | HCA HOLDINGS INC | $19,942,000 | – | 553,020 | +100.0% | 0.94% | – |
ARNA | New | ARENA PHARMACEUTICALS INC | $19,778,000 | – | 2,568,588 | +100.0% | 0.93% | – |
ACAD | New | ACADIA PHARMACEUTICALS INC | $19,368,000 | – | 1,067,115 | +100.0% | 0.91% | – |
THC | New | TENET HEALTHCARE CORP | $18,814,000 | – | 408,120 | +100.0% | 0.89% | – |
PCYC | New | PHARMACYCLICS INC | $18,042,000 | – | 227,030 | +100.0% | 0.85% | – |
HUM | New | HUMANA INC | $15,863,000 | – | 188,000 | +100.0% | 0.75% | – |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $13,768,000 | – | 247,000 | +100.0% | 0.65% | – |
New | DENDREON CORPnote 4.750% 6/1 | $13,611,000 | – | 13,740,000 | +100.0% | 0.64% | – | |
EW | New | EDWARDS LIFESCIENCES CORPcall | $13,440,000 | – | 200,000 | +100.0% | 0.63% | – |
ACHN | New | ACHILLION PHARMACEUTICALS IN | $13,332,000 | – | 1,629,833 | +100.0% | 0.63% | – |
PTLA | New | PORTOLA PHARMACEUTICALS INC | $12,958,000 | – | 527,410 | +100.0% | 0.61% | – |
CEMP | New | CEMPRA INC | $12,483,000 | – | 1,606,510 | +100.0% | 0.59% | – |
PACB | New | PACIFIC BIOSCIENCES CALIF IN | $12,357,000 | – | 4,884,368 | +100.0% | 0.58% | – |
BDSI | New | BIODELIVERY SCIENCES INTL IN | $10,627,000 | – | 2,617,586 | +100.0% | 0.50% | – |
DNDNQ | New | DENDREON CORPput | $10,300,000 | – | 2,500,000 | +100.0% | 0.48% | – |
IART | New | INTEGRA LIFESCIENCES HLDGS C | $9,452,000 | – | 258,044 | +100.0% | 0.45% | – |
SGEN | New | SEATTLE GENETICS INCput | $9,438,000 | – | 300,000 | +100.0% | 0.44% | – |
RIGL | New | RIGEL PHARMACEUTICALS INC | $9,052,000 | – | 2,710,053 | +100.0% | 0.43% | – |
DEPO | New | DEPOMED INC | $8,458,000 | – | 1,505,000 | +100.0% | 0.40% | – |
CCRN | New | CROSS CTRY HEALTHCARE INC | $8,164,000 | – | 1,582,227 | +100.0% | 0.38% | – |
ARAY | New | ACCURAY INC | $8,151,000 | – | 1,420,000 | +100.0% | 0.38% | – |
New | INTERMUNE INCnote 2.500%12/1 | $8,025,000 | – | 7,500,000 | +100.0% | 0.38% | – | |
MDRX | New | ALLSCRIPTS HEALTHCARE SOLUTN | $8,015,000 | – | 619,360 | +100.0% | 0.38% | – |
LPDX | New | LIPOSCIENCE INC | $7,708,000 | – | 1,102,744 | +100.0% | 0.36% | – |
OVAS | New | OVASCIENCE INC | $7,628,000 | – | 555,555 | +100.0% | 0.36% | – |
ATEC | New | ALPHATEC HOLDINGS INC | $7,529,000 | – | 3,672,604 | +100.0% | 0.36% | – |
INSM | New | INSMED INC | $6,623,000 | – | 553,793 | +100.0% | 0.31% | – |
ZGNX | New | ZOGENIX INC | $6,581,000 | – | 3,848,572 | +100.0% | 0.31% | – |
ANTH | New | ANTHERA PHARMACEUTICALS INC | $6,434,000 | – | 13,893,465 | +100.0% | 0.30% | – |
New | ACCURAY INCnote 3.500% 2/0 | $6,256,000 | – | 5,000,000 | +100.0% | 0.30% | – | |
ATRC | New | ATRICURE INC | $5,985,000 | – | 630,000 | +100.0% | 0.28% | – |
MEIP | New | MEI PHARMA INC | $5,862,000 | – | 822,199 | +100.0% | 0.28% | – |
New | ALERE INCnote 3.000% 5/1 | $5,710,000 | – | 5,750,000 | +100.0% | 0.27% | – | |
DRTX | New | DURATA THERAPEUTICS INC | $5,418,000 | – | 752,539 | +100.0% | 0.26% | – |
XOMA | New | XOMA CORP DEL | $4,356,000 | – | 1,200,000 | +100.0% | 0.20% | – |
FRX | New | FOREST LABS INCcall | $4,100,000 | – | 100,000 | +100.0% | 0.19% | – |
VCRA | New | VOCERA COMMUNICATIONS INC | $4,026,000 | – | 273,858 | +100.0% | 0.19% | – |
TTPH | New | TETRAPHASE PHARMACEUTICALS I | $3,901,000 | – | 554,898 | +100.0% | 0.18% | – |
New | MANNKIND CORPnote 5.750% 8/1 | $2,725,000 | – | 2,500,000 | +100.0% | 0.13% | – | |
AMED | New | AMEDISYS INC | $2,704,000 | – | 233,066 | +100.0% | 0.13% | – |
LCAV | New | LCA-VISION INC | $2,509,000 | – | 830,856 | +100.0% | 0.12% | – |
MRGE | New | MERGE HEALTHCARE INC | $2,479,000 | – | 688,510 | +100.0% | 0.12% | – |
DYAX | New | DYAX CORP | $2,352,000 | – | 679,866 | +100.0% | 0.11% | – |
ELN | New | ELAN PLCadr | $2,334,000 | – | 165,084 | +100.0% | 0.11% | – |
DSCO | New | DISCOVERY LABORATORIES INC N | $2,026,000 | – | 1,333,000 | +100.0% | 0.10% | – |
New | MANNKIND CORPnote 3.750%12/1 | $2,022,000 | – | 2,090,000 | +100.0% | 0.10% | – | |
RAD | New | RITE AID CORP | $2,002,000 | – | 700,000 | +100.0% | 0.09% | – |
GILD | New | GILEAD SCIENCES INC | $1,794,000 | – | 35,000 | +100.0% | 0.08% | – |
MSTX | New | MAST THERAPEUTICS INC | $1,695,000 | – | 3,948,302 | +100.0% | 0.08% | – |
CTRX | New | CATAMARAN CORP | $1,463,000 | – | 30,000 | +100.0% | 0.07% | – |
New | AUXILIUM PHARMACEUTICALS INCnote 1.500% 7/1 | $1,452,000 | – | 1,500,000 | +100.0% | 0.07% | – | |
PTN | New | PALATIN TECHNOLOGIES INC | $1,240,000 | – | 2,000,000 | +100.0% | 0.06% | – |
IRWD | New | IRONWOOD PHARMACEUTICALS INCput | $993,000 | – | 100,000 | +100.0% | 0.05% | – |
BONE | New | BACTERIN INTL HLDGS INC | $866,000 | – | 1,924,386 | +100.0% | 0.04% | – |
GTIV | New | GENTIVA HEALTH SERVICES INC | $775,000 | – | 77,839 | +100.0% | 0.04% | – |
SLTM | New | SOLTA MED INC | $773,000 | – | 339,063 | +100.0% | 0.04% | – |
WCRX | New | WARNER CHILCOTT PLC IRELAND | $688,000 | – | 34,543 | +100.0% | 0.03% | – |
HOLX | New | HOLOGIC INC | $676,000 | – | 35,000 | +100.0% | 0.03% | – |
ILMN | New | ILLUMINA INC | $629,000 | – | 8,399 | +100.0% | 0.03% | – |
MYGN | New | MYRIAD GENETICS INC | $505,000 | – | 18,777 | +100.0% | 0.02% | – |
QCOR | New | QUESTCOR PHARMACEUTICALS INC | $454,000 | – | 10,000 | +100.0% | 0.02% | – |
LHCG | New | LHC GROUP INC | $374,000 | – | 19,087 | +100.0% | 0.02% | – |
ECYT | New | ENDOCYTE INC | $364,000 | – | 27,708 | +100.0% | 0.02% | – |
ALKS | New | ALKERMES PLC | $315,000 | – | 11,000 | +100.0% | 0.02% | – |
AFAM | New | ALMOST FAMILY INC | $252,000 | – | 13,200 | +100.0% | 0.01% | – |
SPPI | New | SPECTRUM PHARMACEUTICALS INC | $237,000 | – | 31,750 | +100.0% | 0.01% | – |
ICAD | New | ICAD INC | $233,000 | – | 38,887 | +100.0% | 0.01% | – |
OREX | New | OREXIGEN THERAPEUTICS INC | $132,000 | – | 22,575 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
EHEALTH INC | 25 | Q3 2020 | 2.0% |
INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
MYLAN NV | 23 | Q3 2020 | 6.2% |
PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-19 |
4 | 2024-03-19 |
4 | 2024-03-12 |
3 | 2024-03-08 |
4 | 2024-02-16 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
3 | 2024-02-01 |
4 | 2023-11-21 |
13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.